RE:I read the NR again
I read the news report as well and would say it was okay. I fully agree the right decision was made by Dr. Berendt to delay the BLA submission to the FDA by 3 more months ensuring the company is best positioned for the official BLA submission to the FDA after yesterday's Type C facility meeting as opposed to just go forward to meet a timeline. All in all, I think everything is okay.
However, it's VERY frustrating as a longtime shareholder that it just seems everytime the company puts out any kind of news report, the share price inevitably drifts lower after the report. Why can't it ever seem to surprise on the upside for a change with something really positive, and reward the shareholders.
Oh well, just have to wait longer I guess.